0001209191-21-049605.txt : 20210804
0001209191-21-049605.hdr.sgml : 20210804
20210804160957
ACCESSION NUMBER: 0001209191-21-049605
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210802
FILED AS OF DATE: 20210804
DATE AS OF CHANGE: 20210804
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Andrews William T.
CENTRAL INDEX KEY: 0001638459
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36287
FILM NUMBER: 211144081
MAIL ADDRESS:
STREET 1: ONE MAIN STREET, SUITE 800
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Flexion Therapeutics Inc
CENTRAL INDEX KEY: 0001419600
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10 MALL ROAD
STREET 2: SUITE 301
CITY: BURLINGTON
STATE: MA
ZIP: 01803
BUSINESS PHONE: (781) 305-7777
MAIL ADDRESS:
STREET 1: 10 MALL ROAD
STREET 2: SUITE 301
CITY: BURLINGTON
STATE: MA
ZIP: 01803
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-08-02
0
0001419600
Flexion Therapeutics Inc
FLXN
0001638459
Andrews William T.
C/O FLEXION THERAPEUTICS, INC.
10 MALL ROAD, SUITE 301
BURLINGTON
MA
01803
0
1
0
0
Chief Medical Officer
Common Stock
2021-08-02
4
A
0
34250
0.00
A
34250
D
Stock option (right to buy)
6.25
2021-08-02
4
A
0
205500
0.00
A
2031-08-01
Common Stock
205500
205500
D
Represents a restricted stock unit award granted under the Issuer's 2013 Equity Incentive Plan.
25% of the shares subject to the option shall vest on the one-year anniversary of July 1, 2021 (the "Vesting Commencement Date"), and 1/48th of the shares subject to the option shall vest each month following the one-year anniversary of the Vesting Commencement Date, so that all of the shares subject to the options shall be vested four years after the Vesting Commencement Date.
/s/ Mark S. Levine, Attorney-in-Fact
2021-08-04